BioSpace News Archive

Deals

Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 2019

The live webcast of the call can be accessed at the company’s Investors page at http://investors.gilead.com/.

July 16, 2019
·
1 min read
Business

Seattle Genetics Reports Second Quarter 2019 Financial Results

Seattle Genetics, Inc. reported financial results for the second quarter and six months ended June 30, 2019.

July 16, 2019
·
13 min read
FDA

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3

Arrowhead Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has granted orphan drug designation to ARO-ANG3 for the treatment of homozygous familial hypercholesterolemia.

July 16, 2019
·
4 min read
Deals

AVROBIO Announces Proposed Public Offering of Common Stock

AVROBIO, Inc. announced that it intends to offer and sell, subject to market and other conditions, $100.0 million of its common stock in an underwritten public offering.

July 16, 2019
·
4 min read
Deals

Aratana Therapeutics’ Stockholders Adopt Merger Agreement with Elanco Animal Health

Aratana Reports Voting Results from 2019 Special Meeting of Stockholders

July 16, 2019
·
4 min read
Drug Development

Tradipitant Effective in Preventing Motion Sickness

Vanda Pharmaceuticals Inc. announced that tradipitant, a neurokinin-1 receptor antagonist, was effective in treating motion sickness in a clinical study conducted in the Pacific Ocean.

July 16, 2019
·
7 min read
Business

BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer

BioPharmX Corporation, a specialty pharmaceutical company focused on developing innovative medical dermatology products, announces the appointment of Steven M. Bosacki, a 20 year pharmaceutical industry veteran, as its Chief Operating Officer.

July 16, 2019
·
4 min read
Deals

Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference Call

Charles River Laboratories International, Inc. will release second-quarter 2019 financial results on Wednesday, July 31st, before the market opens.

July 16, 2019
·
1 min read
Deals

Senseonics Announces Public Offering of Common Stock - July 16, 2019

Senseonics Holdings, Inc. announced that it has commenced a registered underwritten public offering of $25.0 million of its shares of common stock.

July 16, 2019
·
4 min read
Business

Senseonics Holdings, Inc. Reports Preliminary Second Quarter 2019 Net Revenue

Senseonics Holdings, Inc. announced preliminary financial results for the second quarter of 2019.

July 16, 2019
·
4 min read